shortage of glp-1 receptor agonists Agonist Market Growth Analysis GLP-1 Drug Savings: A Complete
Description
Crajoinas, R
Combination of basal insulin and GLP-1 receptor agonist: Is this the end of basal insulin alone in the treatment of type 2 diabetes
doi: 10.1016/S2213-8587(22)00116-4 [DOI] [PubMed] [Google Scholar] 198.Giugliano D, Scappaticcio L, Longo M, et al
Preserved incretin activity of glucagon-like peptide 1 [7-36 amide] but not of synthetic human gastric inhibitory polypeptide in patients with type-2 diabetes mellitus
No other approved or late-stage investigational compound does this
